{
    "clinical_study": {
        "@rank": "156330", 
        "arm_group": {
            "arm_group_label": "NI-0501", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the safety, tolerability and preliminary efficacy of\n      a new drug aimed at controlling disease reactivation in patients diagnosed with primary\n      haemophagocytic lymphohistiocytosis and having previously shown partial response to current\n      recommended treatment. The new drug will be administered on top of a glucocorticosteroid,\n      which is usually part of the current recommended treatment."
        }, 
        "brief_title": "A Study to Investigate the Safety and Efficacy of an Anti-IFN\u03b3 mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis", 
        "condition": "Primary Hemophagocytic Lymphohistiocytosis", 
        "condition_browse": {
            "mesh_term": "Lymphohistiocytosis, Hemophagocytic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gender: male and female\n\n          -  Age: up to and including 18 years at diagnosis of Haemophagocytic Lymphohistiocytosis\n\n          -  Primary HLH patients who have previously achieved at least partial response to\n             conventional induction therapy and who present a reactivation of the disease\n\n          -  Patient (if \u2265 18 years old), or patient's legal representative(s) must have signed\n             informed consent\n\n        Exclusion Criteria:\n\n          -  Diagnosis of secondary Haemophagocytic Lymphohistiocytosis consequent to a proven\n             rheumatic or neoplastic disease.\n\n          -  Body weight < 3 kg.\n\n          -  Patients treated with biologics within a specific timeframe\n\n          -  Reactivation associated with isolated or multiple acute organ failure(s) (heart, lung\n             or kidney) requiring aggressive therapy such as high dose of inotropic drugs,\n             circulatory assistance, hemofiltration or haemodialysis, artificial ventilation.\n\n          -  Active infections.\n\n          -  History of malignancy.\n\n          -  Concomitant disease or malformation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818492", 
            "org_study_id": "NI-0501-04", 
            "secondary_id": "2012-003632-23"
        }, 
        "intervention": {
            "arm_group_label": "NI-0501", 
            "intervention_name": "NI-0501", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Jonathan.Powell@nemours.org", 
                    "last_name": "Jonathan Powell, MD", 
                    "phone": "302-651-5505"
                }, 
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "Delaware", 
                        "zip": "19803"
                    }, 
                    "name": "Alfred I. duPont Hospital for Children - Nemours Center for Cancer and Blood Disorders - Division of Pediatric Hematology Oncology"
                }, 
                "investigator": {
                    "last_name": "Jonathan Powell, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Barbara_Degar@dfci.harvard.edu", 
                    "last_name": "Barbara A Degar, MD", 
                    "phone": "617-632-5186"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Dana-Farber Cancer Institute (DFCI)"
                }, 
                "investigator": {
                    "last_name": "Barbara A Degar, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Michael.Jordan@cchmc.org", 
                    "last_name": "Michael Jordan, MD", 
                    "phone": "513-636-7287"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }, 
                    "name": "Cincinnati Children's Hospital - Division of Immunobiology - Department of Pediatrics"
                }, 
                "investigator": {
                    "last_name": "Michael Jordan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ceallen@txch.org", 
                    "last_name": "Carl Allen, MD, PhD", 
                    "phone": "832-824-4312"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Texas Children's Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Carl Allen, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wolfgang.holter@stanna.at", 
                    "last_name": "Wolfgang Holter, MD", 
                    "phone": "0043 1 40 170 1250"
                }, 
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "Austria", 
                        "zip": "A-1090"
                    }, 
                    "name": "St. Anna Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Wolfgang Holter, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "petr.sedlacek@lfmotol.cuni.cz", 
                    "last_name": "Petr Sedlacek, MD", 
                    "phone": "0042 0224436401"
                }, 
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic", 
                        "zip": "150 06"
                    }, 
                    "name": "Charles University Prague University Hospital Motol - Department of Pediatric Hematology and Oncology"
                }, 
                "investigator": {
                    "last_name": "Petr Sedlacek, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jurgh@uni-muenster.de", 
                    "last_name": "Herbert Jurgens, MD", 
                    "phone": "0049 2518347941"
                }, 
                "facility": {
                    "address": {
                        "city": "Munster", 
                        "country": "Germany", 
                        "zip": "48149"
                    }, 
                    "name": "University Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Herbert Jurgens, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "f.bambi@meyer.it", 
                    "last_name": "Franco Bambi, MD", 
                    "phone": "+39 055-5662", 
                    "phone_ext": "991"
                }, 
                "facility": {
                    "address": {
                        "city": "Florence", 
                        "country": "Italy", 
                        "zip": "50139"
                    }, 
                    "name": "Azienda Ospedaliero Universitaria Meyer"
                }, 
                "investigator": {
                    "last_name": "Franco Bambi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "concettamicalizzi@ospedale-gaslini.ge.it", 
                    "last_name": "Concetta Micalizzi, MD", 
                    "phone": "0039_010_5636", 
                    "phone_ext": "715"
                }, 
                "facility": {
                    "address": {
                        "city": "Genoa", 
                        "country": "Italy", 
                        "zip": "16147"
                    }, 
                    "name": "Istituto Giannina Gaslini"
                }, 
                "investigator": {
                    "last_name": "Concetta Micalizzi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "c.rizzari@hsgerardo.org", 
                    "last_name": "Carmelo Rizzari, MD", 
                    "phone": "0039_039_233", 
                    "phone_ext": "3513"
                }, 
                "facility": {
                    "address": {
                        "city": "Monza", 
                        "country": "Italy", 
                        "zip": "20900"
                    }, 
                    "name": "Azienda Ospedaliera San Gerardo"
                }, 
                "investigator": {
                    "last_name": "Carmelo Rizzari, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "carmendefusco@iol.it", 
                    "last_name": "Carmen De Fusco, MD", 
                    "phone": "0039_081_2205410"
                }, 
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "Italy", 
                        "zip": "80123"
                    }, 
                    "name": "Azienda Ospedaliera Santobono Pausilipon"
                }, 
                "investigator": {
                    "last_name": "Carmen De Fusco, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mariacaterina.putti@unipd.it", 
                    "last_name": "MariaCaterina Putti, MD", 
                    "phone": "0039 049 8213535"
                }, 
                "facility": {
                    "address": {
                        "city": "Padua", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Azienda Ospedaliera Padova - Clinica di Oncoematologia Pediatrica"
                }, 
                "investigator": {
                    "last_name": "Mariacaterina Putti, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "franco.locatelli@opbg.net", 
                    "last_name": "Franco Locatelli, MD", 
                    "phone": "0039 06 68592678"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00165"
                    }, 
                    "name": "Ospedale Pediatrico Bambino Gesu'"
                }, 
                "investigator": {
                    "last_name": "Franco Locatelli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "franca.fagioli@unito.it", 
                    "last_name": "Franca Fagioli, MD", 
                    "phone": "0039 011 313 5259"
                }, 
                "facility": {
                    "address": {
                        "city": "Turin", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "A.O. Regina Margherita / S. Anna - Unit\u00e0 di Oncoematologia"
                }, 
                "investigator": {
                    "last_name": "Franca Fagioli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jossanchez@vhebron.net", 
                    "last_name": "Jose Sanchez de Toledo, MD", 
                    "phone": "0034 934893093"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "119-129"
                    }, 
                    "name": "Hospital Universitario Vall d'Hebron"
                }, 
                "investigator": {
                    "last_name": "Jose Sanchez de Toledo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "itziar.astigarraga@osakidetza.net", 
                    "last_name": "Itziar Astigarraga, MD", 
                    "phone": "0034 946006357"
                }, 
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain", 
                        "zip": "48903"
                    }, 
                    "name": "Hospital Universitario Cruces"
                }, 
                "investigator": {
                    "last_name": "Itziar Astigarraga, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lalsina@hsjdbcn.org", 
                    "last_name": "Laia Alsina Manrique de Lara, MD", 
                    "phone": "0034 932804000", 
                    "phone_ext": "3330"
                }, 
                "facility": {
                    "address": {
                        "city": "Esplugues de Llobregat (Barcelona)", 
                        "country": "Spain", 
                        "zip": "08950"
                    }, 
                    "name": "Hospital Sant Joan de D\u00e9u"
                }, 
                "investigator": {
                    "last_name": "Laia Alsina, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lassaalvaro@yahoo.com", 
                    "last_name": "Alvaro Lassaletta Atienza, MD", 
                    "phone": "0034 915035938"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28009"
                    }, 
                    "name": "Hospital Universitario Ni\u00f1o Jes\u00fas"
                }, 
                "investigator": {
                    "last_name": "Alvaro Lassaletta, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Austria", 
                "Czech Republic", 
                "Germany", 
                "Italy", 
                "Spain"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot, Open-label, Single Arm, Multicentre Study to Explore Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (Anti-IFN\u03b3) Monoclonal Antibody, in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis Which Has Reactivated.", 
        "other_outcome": {
            "description": "Evolution of clinical signs (such as fever, splenomegaly, central nervous system symptoms) and laboratory parameters (such as complete blood cell count, fibrinogen, serum triglycerides, ferritin, soluble Interleukin-2 receptor levels), which characterize the disease, to assess response and time to response.", 
            "measure": "Preliminary efficacy", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "overall_contact": {
            "email": "cdemin@novimmune.com", 
            "last_name": "Cristina de Min, MD", 
            "phone": "+41-22-593-", 
            "phone_ext": "5116"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: The Italian Medicines Agency", 
                "Austria: Federal Office for Safety in Health Care", 
                "Czech Republic: State Institute for Drug Control", 
                "Germany: Paul Ehrlich Institute, PEI", 
                "Spain: Agencia Espanola de Medicamentos y Productos Sanitarios AEMPS", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Vital signs\nPhysical examination\nRecording of adverse Events\nRoutine laboratory assessments", 
            "measure": "Safety and tolerability of NI-0501 in haemophagocytic lymphohistiocytosis", 
            "safety_issue": "Yes", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818492"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "NovImmune SA", 
        "sponsors": {
            "collaborator": {
                "agency": "7th Framework Programme", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "NovImmune SA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}